Clinical trial
The Effect of Addition of Enoxaparin to Neoadjuvant Chemoradiation of Esophageal Cancer on the Clinical and Pathologic Response
NCT03254511 is registered in ClinicalTrials.gov with Mashhad University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Addition of Enoxaparin to Neoadjuvant Chemoradiation of Esophageal Cancer on the Clinical and Pathologic Response
- Lead sponsor
- Mashhad University of Medical Sciences
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- July 22, 2016
- Completion date
- December 30, 2018
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.